8,517 articles
Michael K. Gould
Michael K. Gould is an American pulmonologist and health services researcher at Kaiser Permanente in California, known for his 2014 New England Journal of Medicine review of low-dose CT lung-cancer screening.
Michael K. Mansour
Michael K. Mansour is an infectious-diseases physician-scientist at Massachusetts General Hospital and Harvard Medical School, known for research on how the immune system recognizes fungal pathogens and for a 2020 tocilizumab Covid-19 trial.
Michael Kaliner
Michael Kaliner is an American allergist who directed the Allergic Diseases Section at NIH and founded the Institute for Asthma & Allergy in Chevy Chase, Maryland.
Michael Klompas
Michael Klompas is a Canadian-trained infectious disease physician and hospital epidemiologist at Brigham and Women's Hospital and Harvard whose EHR-based sepsis surveillance shaped CDC definitions.
Michael L. Barnett
Michael L. Barnett is an American physician and health services researcher who studies opioid prescribing, payment reform, and post-acute care, and is a professor at Brown University.
Michael L. Steer
Michael L. Steer (1939–2019) was an American surgeon-scientist at Harvard Medical School and Beth Israel who pioneered pancreatitis cell biology, establishing that acute pancreatitis begins within acinar cells.
Michael Lanzer
Michael Lanzer (born 1959 in Düsseldorf) is a German parasitologist who studies the malaria parasite Plasmodium falciparum, heading Parasitology at Heidelberg University Hospital since 1999.
Michael Laposata
Michael Laposata is an American pathologist and laboratory medicine specialist in blood coagulation, chair of pathology at the University of Texas Medical Branch in Galveston since 2014.
Michael Lesch
Michael Lesch (1939–2008) was an American cardiologist who co-described Lesch–Nyhan syndrome at Johns Hopkins in 1964 and later served as chief of internal medicine at St. Luke's-Roosevelt Hospital Center.
Michael Levin (medical researcher)
Michael Levin is a pediatric infectious diseases consultant and Chair in Paediatrics and International Child Health at Imperial College London, known for research on meningococcal disease and childhood tuberculosis.
Michael M. Frank
Michael M. Frank (1937–2019) was an American immunologist and pediatrician at NIH and Duke University whose laboratory established the first effective drug treatments for hereditary angioedema.
Michael M. Gottesman
Michael M. Gottesman is an American physician-scientist at the National Cancer Institute whose laboratory showed that the P-glycoprotein pump drives multidrug resistance in cancer cells.
Michael Marmot
Sir Michael Marmot, born 1945, is a British epidemiologist at University College London known for the Whitehall studies, the social gradient, and the 2010 Marmot Review.
Michael Mulholland
Michael Mulholland is an American surgeon and scientist who chaired the University of Michigan Department of Surgery from 2002 and is known for pancreatic and biliary research.
Michael Nauck
Michael Nauck is a German physician and diabetes researcher at Ruhr University Bochum whose work on incretin hormones GIP and GLP-1 shaped type 2 diabetes therapy.
Michael O. Thorner
Michael O. Thorner is a British-trained neuroendocrinologist who joined the University of Virginia in 1977, known for growth hormone research, GHRH discovery work, and pegvisomant studies.
Michael Osterholm
Michael Osterholm, American infectious disease epidemiologist, Regents Professor and director of CIDRAP at the University of Minnesota; former Minnesota state epidemiologist (1984–1999), Biden COVID-19 transition adviser, and author of Deadliest Enemy and The Big One.
Michael P. Busch
Michael P. Busch is an American transfusion-medicine researcher known for developing nucleic acid testing of the blood supply for HIV, hepatitis C, and West Nile virus.
Michael P. Czech
Michael P. Czech is an American molecular biologist and biochemist at UMass Chan Medical School known for work on insulin signaling and RNAi and CRISPR therapies for diabetes.
Michael P. Link
Michael P. Link is an American pediatric oncologist at Stanford University whose 1986 osteosarcoma and lymphoma trials transformed childhood cancer treatment; he was ASCO's first pediatric oncologist president.
Michael P. Madaio
Michael P. Madaio is an American nephrologist and autoimmunity researcher, emeritus at Augusta University, whose laboratory showed how anti-DNA antibodies enter living cells and drive lupus nephritis.
Michael P. Manns
Michael P. Manns was a German hepatologist who directed hepatology at Medizinische Hochschule Hannover from 1991 to 2020 and set treatment standards for viral hepatitis B, C, and D.
Michael P. Whyte
Michael P. Whyte is an American physician-scientist at Washington University in St. Louis whose work on hypophosphatasia led to enzyme-replacement therapy approved for pediatric-onset cases since 2015.
Michael Pfreundschuh
Michael Pfreundschuh (1949–2018) was a German hematologist and oncologist, professor at Saarland University in Homburg, who developed the SEREX method for identifying human tumor antigens.
Michael Platten
Michael Platten is a German neurologist and neuroimmunologist who leads brain tumor immunotherapy research at Heidelberg University, University Medicine Mannheim, and the German Cancer Research Center.
Michaël Pollak
Michaël Pollak, also published as Michael N. Pollak, is a medical oncologist and cancer researcher at McGill University in Montreal, known for work on insulin, IGF signaling, and metformin in cancer.
Michael Potter
Michael Potter (1924–2013) was an American immunologist and physician at the National Cancer Institute whose mineral-oil-induced mouse tumors enabled hybridoma technology; he won the 1984 Lasker Award.
Michael R. Bristow
Michael R. Bristow (1946–c. 2026) was an American cardiologist at the University of Colorado Denver whose work on beta-adrenergic receptors established beta-blocker therapy for heart failure.
Michael R. DeBaun
Michael R. DeBaun is an American pediatric hematologist at Vanderbilt University whose research on silent strokes changed sickle cell disease treatment, and who helped write the 2004 Sickle Cell Treatment Act.
Michael R. Hayden
Michael R. Hayden, born 1951 in Cape Town, South Africa, is a physician-scientist at the University of British Columbia known for Huntington disease genetics and co-founding five biotechnology companies.